Alector ALEC
NASDAQ ALEC
$2.63 +0.10 (+3.95%)
At close: Nov 11, 2026 · 4:00 PM EST

Alector (ALEC) Return on Invested Capital [ROIC] (2025 - 2026)

Updated

Alector (ALEC) posted Return on Invested Capital [ROIC] of -1263.15% for Q2 2026, down 1117.56 percentage points from -145.59% a year earlier and down 812.71 percentage points from the prior quarter.

Analysis

Alector (ALEC) Return on Invested Capital [ROIC] (2025 - 2026) Analysis & Trends

For FY2025, Alector's Return on Invested Capital [ROIC] came in at -176.75%, down 69.48 percentage points from FY2024.

  • In prior years, Alector's Return on Invested Capital [ROIC] was -107.27% in FY2024.
  • According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was -450.45% (Q1 2026), -289.81% (Q4 2025) and -167.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Alector 284.06 Mn -489.98 Mn - 59.53%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 59.53%
Jun 30, 2026 -1,263.15%
Mar 31, 2026 -450.45%
Dec 31, 2025 -289.81%
Sep 30, 2025 -167.11%
Jun 30, 2025 -145.59%
Mar 31, 2025 -121.52%
API Access

Alector Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ALEC&period=max&api_key=YOUR_API_KEY